IVF Services Market: By Gender (Male Infertility, Female Infertility, Others), By Procedure (ICSI IVF, Non-ICSI IVF, IUI), By Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles, Donor Egg IVF Cycles) By End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes) By Offering (IVF Drugs, IVF Media and Reagents, IVF and IUI Services) and Geography

IVF Services Market size was valued at USD 877.5 million in 2023 and is poised to grow at a significant CAGR of 17.8% from 2024-2030. IVF is a sort of assisted reproductive technology (ART) that involves extracting eggs from a woman's ovaries and letting sperm fertilize in laboratory conditions. The technique involves stimulating a woman's ovulatory system, extracting an ovum from her ovaries, and fertilizing it in a liquid laboratory using sperm. The ICSI IVF segment is anticipated to grow at a significant CAGR over the forecast years owing to the success rate of fertilization with the ICSI method, as well as the increasing use of ICSI during IVF operation, which is expected to raise the adoption of IVF with ICSI treatments, driving the segment's growth throughout the projected period. Moreover, the market player is focusing on launching new products, acquisitions, and collaboration to maintain growth in the market.  The availability of treatment options and increased public knowledge regarding infertility are two significant factors driving the growth of this industry. However, the high cost and poor success rate of IVF therapy, as well as tight laws and ethical issues, are projected to limit the IVF market's growth to some extent.

IVF Services Market Key Developments:

• In 2021 Hamilton Thorne Ltd. gained FDA permission to commercialize the GYNEMED GM501, a ready-to-use medium developed for in vitro washing and handling operations of human oocytes and embryos in the United States and Europe.
• In 2020 FUJIFILM Irvine Scientific announced the release of Vit Kit-NX, a vitrification media solution.